Literature DB >> 18787912

Gluten ataxia.

Marios Hadjivassiliou1, David S Sanders, Nicola Woodroofe, Claire Williamson, Richard A Grünewald.   

Abstract

Gluten ataxia is an immune-mediated disease triggered by the ingestion of gluten in genetically susceptible individuals. It should be considered in the differential diagnosis of all patients with idiopathic sporadic ataxia. Early diagnosis and treatment with a gluten free diet can improve ataxia and prevent its progression. Readily available and sensitive markers of gluten ataxia include antigliadin antibodies. IgA deposits against TG2 in the small bowel and at extraintestinal sites are proving to be additional reliable and perhaps more specific markers of the whole spectrum of gluten sensitivity. They may also hold the key to its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787912     DOI: 10.1007/s12311-008-0052-x

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  28 in total

1.  Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet.

Authors:  M T Pellecchia; R Scala; A Perretti; G De Michele; L Santoro; A Filla; C Ciacci; P Barone
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

2.  Opsoclonus-myoclonus associated with celiac disease.

Authors:  Nicolas Deconinck; Michèle Scaillon; Valérie Segers; José J Groswasser; Bernard Dan
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

Review 3.  The immunology of gluten sensitivity: beyond the gut.

Authors:  Marios Hadjivassiliou; Clare A Williamson; Nicola Woodroofe
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

4.  Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia.

Authors:  I D Wilkinson; M Hadjivassiliou; J M Dickson; L Wallis; R A Grünewald; S C Coley; E Widjaja; P D Griffiths
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

5.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

6.  Gluten sensitivity in sporadic and hereditary cerebellar ataxia.

Authors:  K O Bushara; S U Goebel; H Shill; L G Goldfarb; M Hallett
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

7.  Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia.

Authors:  Masafumi Ihara; Fumi Makino; Hideyuki Sawada; Takahiro Mezaki; Kotaro Mizutani; Hiroshi Nakase; Makoto Matsui; Hidekazu Tomimoto; Shun Shimohama
Journal:  Intern Med       Date:  2006-03-01       Impact factor: 1.271

8.  Coeliac disease in patients with cerebellar ataxia of unknown origin.

Authors:  L K Luostarinen; P O Collin; M J Peräaho; M J Mäki; T A Pirttilä
Journal:  Ann Med       Date:  2001-09       Impact factor: 4.709

9.  Antigliadin antibodies in Huntington's disease.

Authors:  Khalafalla O Bushara; Martha Nance; Christopher M Gomez
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

Review 10.  Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum.

Authors:  K P Bhatia; P Brown; R Gregory; G G Lennox; H Manji; P D Thompson; D W Ellison; C D Marsden
Journal:  Brain       Date:  1995-10       Impact factor: 13.501

View more
  34 in total

1.  Celiac disease: a challenge for all physicians.

Authors:  Srihari Mahadov; Peter H R Green
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

2.  The many faces of celiac disease.

Authors:  Vivian Asamoah; Ranier von Coelln; Joseph Savitt; Linda A Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

Review 3.  Immunologically mediated dementias.

Authors:  Michael H Rosenbloom; Sallie Smith; Gulden Akdal; Michael D Geschwind
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

4.  Hashimoto's encephalopathy mimicking spinocerebellar ataxia.

Authors:  Yi Tang; Changbiao Chu; Michael T Lin; Gangzhi Wei; Xinqing Zhang; Yuwei Da; Hui Huang; Jianping Jia
Journal:  J Neurol       Date:  2011-03-23       Impact factor: 4.849

5.  Silent neurological involvement in biopsy-defined coeliac patients.

Authors:  Basar Bilgic; Demet Aygun; Ali Bilgin Arslan; Ali Bayram; Filiz Akyuz; Serra Sencer; Hasmet A Hanagasi
Journal:  Neurol Sci       Date:  2013-04-25       Impact factor: 3.307

6.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

7.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

8.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 9.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 10.  Coeliac disease and autoimmune disease-genetic overlap and screening.

Authors:  Knut E A Lundin; Cisca Wijmenga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-25       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.